查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1872326

抗生素药物：全球市场份额和排名、总销售额和需求预测（2025-2031年）

Antibiotic Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 134 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024年全球抗生素市场规模估计为525.52亿美元，预计到2031年将达到658.33亿美元，2025年至2031年的复合年增长率为3.2%。

抗生素是一类用于预防和治疗细菌感染疾病的药物，其作用机转是透过抑製或杀死细菌。它们透过靶向细菌生存和生长所必需的特定成分发挥作用，例如细胞壁、蛋白质合成和DNA复製。抗生素广泛用于治疗肺炎、尿道感染、皮肤感染疾病和结核病等感染疾病。根据感染疾病的严重程度和部位，抗生素以多种形式给药，包括口服片剂、静脉注射和外用乳膏。抗生素是现代医学的基石，透过控制细菌感染疾病挽救了无数生命。

全球细菌感染疾病负担日益加重，尤其是在医疗资源匮乏的发展中地区，这推动了抗生素市场的成长。抗生素对于治疗多种感染疾病至关重要，从呼吸道感染疾病等轻微疾病到败血症和结核病等严重。慢性病、医院感染的增加、人口老化也是推动抗生素需求成长的因素。此外，製剂技术的进步，例如新型频谱抗生素的研发和新型给药系统的引入，有助于对抗新出现的抗药性菌株，从而进一步促进市场成长。

然而，抗生素市场面临严峻的挑战，主要源自于抗生素抗药性日益严重的威胁。人类和动物对抗生素的过度使用和滥用会加速抗药性细菌的出现，并降低​​现有疗法的疗效。抗药性问题使得研发新型抗生素的需求迫切，但科学和经济障碍阻碍了抗生素的研发进程。除了高成本外，监管障碍以及抗生素与其他药物相比较短的专利保护期也限制了该领域的投资。此外，人们越来越倾向于选择替代疗法，以及对抗生素残留环境影响的担忧也影响市场动态。

本报告旨在对全球抗生素市场进行全面分析，重点关注总销售额、企业市场占有率和主要企业的排名，以及按地区/国家、类型和应用对抗生素进行分析。

本报告以销售收入为指标，基于2020年至2031年的历史数据和预测数据，对抗生素市场规模、估值和预测进行了阐述，其中2024年为基准年。我们运用定量和定性分析相结合的方法，帮助读者制定业务/成长策略，评估市场竞争格局，分析自身在当前市场中的地位，并就抗生素相关业务做出明智的决策。

市场区隔

公司

  • GSK
  • Pfizer
  • Merck & Co
  • Sandoz
  • Sumitomo Pharma
  • Fresenius
  • AbbVie
  • Hailin Pharmaceuticals
  • Bausch Health
  • Southwest Pharmaceuticals
  • Zhuhai United Pharmaceuticals
  • Qilu Pharmaceuticals
  • China Resources Sanjiu Pharmaceuticals
  • Shenzhen Xinlitai Pharmaceuticals
  • Shanghai Modern Pharmaceuticals
  • North China Pharmaceuticals
  • Sun Pharmaceuticals
  • Hikma Pharmaceuticals
  • Shijiazhuang Pharmaceutical Group
  • Resun Pharmaceuticals

按类型分類的细分市场

  • 口服
  • 注射
  • 其他的

药物分类

  • β-内酰胺类
  • 四环霉素
  • 大环内酯类
  • Aminoglycosides
  • 胜肽
  • 奎诺酮
  • 其他的

应用领域

  • 医院
  • 零售药房
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Antibiotic Drug was estimated to be worth US$ 52552 million in 2024 and is forecast to a readjusted size of US$ 65833 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.

Antibiotics are a class of drugs used to prevent and treat bacterial infections by inhibiting the growth or killing bacteria. They work by targeting specific components of bacterial cells, such as cell walls, protein synthesis, or DNA replication, which are essential for bacterial survival and replication. Antibiotics are widely used in the treatment of infections like pneumonia, urinary tract infections, skin infections, and tuberculosis. They can be administered in various forms, including oral tablets, intravenous injections, and topical creams, depending on the severity and location of the infection. Over time, antibiotics have become a cornerstone of modern medicine, helping to save countless lives by controlling bacterial infections.

The antibiotics drugs market is driven by the growing global burden of bacterial infections, particularly in developing regions where access to healthcare may be limited. Antibiotics are essential for treating a wide range of infections, from minor illnesses like respiratory infections to more severe diseases such as sepsis and tuberculosis. The increasing prevalence of chronic diseases, hospital-acquired infections, and the rising geriatric population are also contributing to the demand for antibiotics. Additionally, advancements in antibiotic formulations, including the development of new broad-spectrum antibiotics and the introduction of novel delivery systems, are helping to address emerging resistant strains of bacteria, further fueling market growth.

However, the antibiotics market faces significant challenges, primarily due to the rising threat of antibiotic resistance. Overuse and misuse of antibiotics in both humans and animals have accelerated the development of resistant bacteria, which can make existing treatments less effective. This resistance has led to the urgent need for new antibiotics, yet the pace of antibiotic discovery has slowed due to scientific and economic barriers. The high cost of research and development, coupled with regulatory hurdles and the shorter patent life of antibiotics compared to other drugs, also limits the investment in this sector. Furthermore, the increasing preference for alternative treatments and concerns over the environmental impact of antibiotic residues are influencing market dynamics.

This report aims to provide a comprehensive presentation of the global market for Antibiotic Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antibiotic Drug by region & country, by Type, and by Application.

The Antibiotic Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Drug.

Market Segmentation

By Company

  • GSK
  • Pfizer
  • Merck & Co
  • Sandoz
  • Sumitomo Pharma
  • Fresenius
  • AbbVie
  • Hailin Pharmaceuticals
  • Bausch Health
  • Southwest Pharmaceuticals
  • Zhuhai United Pharmaceuticals
  • Qilu Pharmaceuticals
  • China Resources Sanjiu Pharmaceuticals
  • Shenzhen Xinlitai Pharmaceuticals
  • Shanghai Modern Pharmaceuticals
  • North China Pharmaceuticals
  • Sun Pharmaceuticals
  • Hikma Pharmaceuticals
  • Shijiazhuang Pharmaceutical Group
  • Resun Pharmaceuticals

Segment by Type

  • Oral
  • Injection
  • Other

Segment by Drug

  • B-lactams
  • Tetracyclines
  • Macrolides
  • Aminoglycosides
  • Peptides
  • Quinolones
  • Other

Segment by Application

  • Hospitals
  • Retail Pharmacy
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Antibiotic Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Antibiotic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Antibiotic Drug in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Antibiotic Drug Product Introduction
  • 1.2 Global Antibiotic Drug Market Size Forecast (2020-2031)
  • 1.3 Antibiotic Drug Market Trends & Drivers
    • 1.3.1 Antibiotic Drug Industry Trends
    • 1.3.2 Antibiotic Drug Market Drivers & Opportunity
    • 1.3.3 Antibiotic Drug Market Challenges
    • 1.3.4 Antibiotic Drug Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Antibiotic Drug Players Revenue Ranking (2024)
  • 2.2 Global Antibiotic Drug Revenue by Company (2020-2025)
  • 2.3 Key Companies Antibiotic Drug Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Antibiotic Drug Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Antibiotic Drug
  • 2.6 Antibiotic Drug Market Competitive Analysis
    • 2.6.1 Antibiotic Drug Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Antibiotic Drug Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Drug as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Oral
    • 3.1.2 Injection
    • 3.1.3 Other
  • 3.2 Global Antibiotic Drug Sales Value by Type
    • 3.2.1 Global Antibiotic Drug Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Antibiotic Drug Sales Value, by Type (2020-2031)
    • 3.2.3 Global Antibiotic Drug Sales Value, by Type (%) (2020-2031)

4 Segmentation by Drug

  • 4.1 Introduction by Drug
    • 4.1.1 B-lactams
    • 4.1.2 Tetracyclines
    • 4.1.3 Macrolides
    • 4.1.4 Aminoglycosides
    • 4.1.5 Peptides
    • 4.1.6 Quinolones
    • 4.1.7 Other
  • 4.2 Global Antibiotic Drug Sales Value by Drug
    • 4.2.1 Global Antibiotic Drug Sales Value by Drug (2020 VS 2024 VS 2031)
    • 4.2.2 Global Antibiotic Drug Sales Value, by Drug (2020-2031)
    • 4.2.3 Global Antibiotic Drug Sales Value, by Drug (%) (2020-2031)

5 Segmentation by Application

  • 5.1 Introduction by Application
    • 5.1.1 Hospitals
    • 5.1.2 Retail Pharmacy
    • 5.1.3 Other
  • 5.2 Global Antibiotic Drug Sales Value by Application
    • 5.2.1 Global Antibiotic Drug Sales Value by Application (2020 VS 2024 VS 2031)
    • 5.2.2 Global Antibiotic Drug Sales Value, by Application (2020-2031)
    • 5.2.3 Global Antibiotic Drug Sales Value, by Application (%) (2020-2031)

6 Segmentation by Region

  • 6.1 Global Antibiotic Drug Sales Value by Region
    • 6.1.1 Global Antibiotic Drug Sales Value by Region: 2020 VS 2024 VS 2031
    • 6.1.2 Global Antibiotic Drug Sales Value by Region (2020-2025)
    • 6.1.3 Global Antibiotic Drug Sales Value by Region (2026-2031)
    • 6.1.4 Global Antibiotic Drug Sales Value by Region (%), (2020-2031)
  • 6.2 North America
    • 6.2.1 North America Antibiotic Drug Sales Value, 2020-2031
    • 6.2.2 North America Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
  • 6.3 Europe
    • 6.3.1 Europe Antibiotic Drug Sales Value, 2020-2031
    • 6.3.2 Europe Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Antibiotic Drug Sales Value, 2020-2031
    • 6.4.2 Asia Pacific Antibiotic Drug Sales Value by Region (%), 2024 VS 2031
  • 6.5 South America
    • 6.5.1 South America Antibiotic Drug Sales Value, 2020-2031
    • 6.5.2 South America Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
  • 6.6 Middle East & Africa
    • 6.6.1 Middle East & Africa Antibiotic Drug Sales Value, 2020-2031
    • 6.6.2 Middle East & Africa Antibiotic Drug Sales Value by Country (%), 2024 VS 2031

7 Segmentation by Key Countries/Regions

  • 7.1 Key Countries/Regions Antibiotic Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 7.2 Key Countries/Regions Antibiotic Drug Sales Value, 2020-2031
  • 7.3 United States
    • 7.3.1 United States Antibiotic Drug Sales Value, 2020-2031
    • 7.3.2 United States Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
    • 7.3.3 United States Antibiotic Drug Sales Value by Application, 2024 VS 2031
  • 7.4 Europe
    • 7.4.1 Europe Antibiotic Drug Sales Value, 2020-2031
    • 7.4.2 Europe Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
    • 7.4.3 Europe Antibiotic Drug Sales Value by Application, 2024 VS 2031
  • 7.5 China
    • 7.5.1 China Antibiotic Drug Sales Value, 2020-2031
    • 7.5.2 China Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
    • 7.5.3 China Antibiotic Drug Sales Value by Application, 2024 VS 2031
  • 7.6 Japan
    • 7.6.1 Japan Antibiotic Drug Sales Value, 2020-2031
    • 7.6.2 Japan Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
    • 7.6.3 Japan Antibiotic Drug Sales Value by Application, 2024 VS 2031
  • 7.7 South Korea
    • 7.7.1 South Korea Antibiotic Drug Sales Value, 2020-2031
    • 7.7.2 South Korea Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
    • 7.7.3 South Korea Antibiotic Drug Sales Value by Application, 2024 VS 2031
  • 7.8 Southeast Asia
    • 7.8.1 Southeast Asia Antibiotic Drug Sales Value, 2020-2031
    • 7.8.2 Southeast Asia Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
    • 7.8.3 Southeast Asia Antibiotic Drug Sales Value by Application, 2024 VS 2031
  • 7.9 India
    • 7.9.1 India Antibiotic Drug Sales Value, 2020-2031
    • 7.9.2 India Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
    • 7.9.3 India Antibiotic Drug Sales Value by Application, 2024 VS 2031

8 Company Profiles

  • 8.1 GSK
    • 8.1.1 GSK Profile
    • 8.1.2 GSK Main Business
    • 8.1.3 GSK Antibiotic Drug Products, Services and Solutions
    • 8.1.4 GSK Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.1.5 GSK Recent Developments
  • 8.2 Pfizer
    • 8.2.1 Pfizer Profile
    • 8.2.2 Pfizer Main Business
    • 8.2.3 Pfizer Antibiotic Drug Products, Services and Solutions
    • 8.2.4 Pfizer Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.2.5 Pfizer Recent Developments
  • 8.3 Merck & Co
    • 8.3.1 Merck & Co Profile
    • 8.3.2 Merck & Co Main Business
    • 8.3.3 Merck & Co Antibiotic Drug Products, Services and Solutions
    • 8.3.4 Merck & Co Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.3.5 Merck & Co Recent Developments
  • 8.4 Sandoz
    • 8.4.1 Sandoz Profile
    • 8.4.2 Sandoz Main Business
    • 8.4.3 Sandoz Antibiotic Drug Products, Services and Solutions
    • 8.4.4 Sandoz Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.4.5 Sandoz Recent Developments
  • 8.5 Sumitomo Pharma
    • 8.5.1 Sumitomo Pharma Profile
    • 8.5.2 Sumitomo Pharma Main Business
    • 8.5.3 Sumitomo Pharma Antibiotic Drug Products, Services and Solutions
    • 8.5.4 Sumitomo Pharma Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.5.5 Sumitomo Pharma Recent Developments
  • 8.6 Fresenius
    • 8.6.1 Fresenius Profile
    • 8.6.2 Fresenius Main Business
    • 8.6.3 Fresenius Antibiotic Drug Products, Services and Solutions
    • 8.6.4 Fresenius Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.6.5 Fresenius Recent Developments
  • 8.7 AbbVie
    • 8.7.1 AbbVie Profile
    • 8.7.2 AbbVie Main Business
    • 8.7.3 AbbVie Antibiotic Drug Products, Services and Solutions
    • 8.7.4 AbbVie Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.7.5 AbbVie Recent Developments
  • 8.8 Hailin Pharmaceuticals
    • 8.8.1 Hailin Pharmaceuticals Profile
    • 8.8.2 Hailin Pharmaceuticals Main Business
    • 8.8.3 Hailin Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.8.4 Hailin Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.8.5 Hailin Pharmaceuticals Recent Developments
  • 8.9 Bausch Health
    • 8.9.1 Bausch Health Profile
    • 8.9.2 Bausch Health Main Business
    • 8.9.3 Bausch Health Antibiotic Drug Products, Services and Solutions
    • 8.9.4 Bausch Health Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.9.5 Bausch Health Recent Developments
  • 8.10 Southwest Pharmaceuticals
    • 8.10.1 Southwest Pharmaceuticals Profile
    • 8.10.2 Southwest Pharmaceuticals Main Business
    • 8.10.3 Southwest Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.10.4 Southwest Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.10.5 Southwest Pharmaceuticals Recent Developments
  • 8.11 Zhuhai United Pharmaceuticals
    • 8.11.1 Zhuhai United Pharmaceuticals Profile
    • 8.11.2 Zhuhai United Pharmaceuticals Main Business
    • 8.11.3 Zhuhai United Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.11.4 Zhuhai United Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.11.5 Zhuhai United Pharmaceuticals Recent Developments
  • 8.12 Qilu Pharmaceuticals
    • 8.12.1 Qilu Pharmaceuticals Profile
    • 8.12.2 Qilu Pharmaceuticals Main Business
    • 8.12.3 Qilu Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.12.4 Qilu Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.12.5 Qilu Pharmaceuticals Recent Developments
  • 8.13 China Resources Sanjiu Pharmaceuticals
    • 8.13.1 China Resources Sanjiu Pharmaceuticals Profile
    • 8.13.2 China Resources Sanjiu Pharmaceuticals Main Business
    • 8.13.3 China Resources Sanjiu Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.13.4 China Resources Sanjiu Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.13.5 China Resources Sanjiu Pharmaceuticals Recent Developments
  • 8.14 Shenzhen Xinlitai Pharmaceuticals
    • 8.14.1 Shenzhen Xinlitai Pharmaceuticals Profile
    • 8.14.2 Shenzhen Xinlitai Pharmaceuticals Main Business
    • 8.14.3 Shenzhen Xinlitai Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.14.4 Shenzhen Xinlitai Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.14.5 Shenzhen Xinlitai Pharmaceuticals Recent Developments
  • 8.15 Shanghai Modern Pharmaceuticals
    • 8.15.1 Shanghai Modern Pharmaceuticals Profile
    • 8.15.2 Shanghai Modern Pharmaceuticals Main Business
    • 8.15.3 Shanghai Modern Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.15.4 Shanghai Modern Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.15.5 Shanghai Modern Pharmaceuticals Recent Developments
  • 8.16 North China Pharmaceuticals
    • 8.16.1 North China Pharmaceuticals Profile
    • 8.16.2 North China Pharmaceuticals Main Business
    • 8.16.3 North China Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.16.4 North China Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.16.5 North China Pharmaceuticals Recent Developments
  • 8.17 Sun Pharmaceuticals
    • 8.17.1 Sun Pharmaceuticals Profile
    • 8.17.2 Sun Pharmaceuticals Main Business
    • 8.17.3 Sun Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.17.4 Sun Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.17.5 Sun Pharmaceuticals Recent Developments
  • 8.18 Hikma Pharmaceuticals
    • 8.18.1 Hikma Pharmaceuticals Profile
    • 8.18.2 Hikma Pharmaceuticals Main Business
    • 8.18.3 Hikma Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.18.4 Hikma Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.18.5 Hikma Pharmaceuticals Recent Developments
  • 8.19 Shijiazhuang Pharmaceutical Group
    • 8.19.1 Shijiazhuang Pharmaceutical Group Profile
    • 8.19.2 Shijiazhuang Pharmaceutical Group Main Business
    • 8.19.3 Shijiazhuang Pharmaceutical Group Antibiotic Drug Products, Services and Solutions
    • 8.19.4 Shijiazhuang Pharmaceutical Group Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.19.5 Shijiazhuang Pharmaceutical Group Recent Developments
  • 8.20 Resun Pharmaceuticals
    • 8.20.1 Resun Pharmaceuticals Profile
    • 8.20.2 Resun Pharmaceuticals Main Business
    • 8.20.3 Resun Pharmaceuticals Antibiotic Drug Products, Services and Solutions
    • 8.20.4 Resun Pharmaceuticals Antibiotic Drug Revenue (US$ Million) & (2020-2025)
    • 8.20.5 Resun Pharmaceuticals Recent Developments

9 Industry Chain Analysis

  • 9.1 Antibiotic Drug Industrial Chain
  • 9.2 Antibiotic Drug Upstream Analysis
    • 9.2.1 Key Raw Materials
    • 9.2.2 Raw Materials Key Suppliers
    • 9.2.3 Manufacturing Cost Structure
  • 9.3 Midstream Analysis
  • 9.4 Downstream Analysis (Customers Analysis)
  • 9.5 Sales Model and Sales Channels
    • 9.5.1 Antibiotic Drug Sales Model
    • 9.5.2 Sales Channel
    • 9.5.3 Antibiotic Drug Distributors

10 Research Findings and Conclusion

11 Appendix

  • 11.1 Research Methodology
    • 11.1.1 Methodology/Research Approach
      • 11.1.1.1 Research Programs/Design
      • 11.1.1.2 Market Size Estimation
      • 11.1.1.3 Market Breakdown and Data Triangulation
    • 11.1.2 Data Source
      • 11.1.2.1 Secondary Sources
      • 11.1.2.2 Primary Sources
  • 11.2 Author Details
  • 11.3 Disclaimer

List of Tables

  • Table 1. Antibiotic Drug Market Trends
  • Table 2. Antibiotic Drug Market Drivers & Opportunity
  • Table 3. Antibiotic Drug Market Challenges
  • Table 4. Antibiotic Drug Market Restraints
  • Table 5. Global Antibiotic Drug Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Antibiotic Drug Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Antibiotic Drug Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Antibiotic Drug Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Antibiotic Drug
  • Table 10. Global Antibiotic Drug Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Drug as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Antibiotic Drug Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Antibiotic Drug Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Antibiotic Drug Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Antibiotic Drug Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Antibiotic Drug Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Antibiotic Drug Sales Value by Drug: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Antibiotic Drug Sales Value by Drug (2020-2025) & (US$ Million)
  • Table 20. Global Antibiotic Drug Sales Value by Drug (2026-2031) & (US$ Million)
  • Table 21. Global Antibiotic Drug Sales Market Share in Value by Drug (2020-2025)
  • Table 22. Global Antibiotic Drug Sales Market Share in Value by Drug (2026-2031)
  • Table 23. Global Antibiotic Drug Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 24. Global Antibiotic Drug Sales Value by Application (2020-2025) & (US$ Million)
  • Table 25. Global Antibiotic Drug Sales Value by Application (2026-2031) & (US$ Million)
  • Table 26. Global Antibiotic Drug Sales Market Share in Value by Application (2020-2025)
  • Table 27. Global Antibiotic Drug Sales Market Share in Value by Application (2026-2031)
  • Table 28. Global Antibiotic Drug Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 29. Global Antibiotic Drug Sales Value by Region (2020-2025) & (US$ Million)
  • Table 30. Global Antibiotic Drug Sales Value by Region (2026-2031) & (US$ Million)
  • Table 31. Global Antibiotic Drug Sales Value by Region (2020-2025) & (%)
  • Table 32. Global Antibiotic Drug Sales Value by Region (2026-2031) & (%)
  • Table 33. Key Countries/Regions Antibiotic Drug Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 34. Key Countries/Regions Antibiotic Drug Sales Value, (2020-2025) & (US$ Million)
  • Table 35. Key Countries/Regions Antibiotic Drug Sales Value, (2026-2031) & (US$ Million)
  • Table 36. GSK Basic Information List
  • Table 37. GSK Description and Business Overview
  • Table 38. GSK Antibiotic Drug Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Antibiotic Drug Business of GSK (2020-2025)
  • Table 40. GSK Recent Developments
  • Table 41. Pfizer Basic Information List
  • Table 42. Pfizer Description and Business Overview
  • Table 43. Pfizer Antibiotic Drug Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Antibiotic Drug Business of Pfizer (2020-2025)
  • Table 45. Pfizer Recent Developments
  • Table 46. Merck & Co Basic Information List
  • Table 47. Merck & Co Description and Business Overview
  • Table 48. Merck & Co Antibiotic Drug Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Antibiotic Drug Business of Merck & Co (2020-2025)
  • Table 50. Merck & Co Recent Developments
  • Table 51. Sandoz Basic Information List
  • Table 52. Sandoz Description and Business Overview
  • Table 53. Sandoz Antibiotic Drug Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Antibiotic Drug Business of Sandoz (2020-2025)
  • Table 55. Sandoz Recent Developments
  • Table 56. Sumitomo Pharma Basic Information List
  • Table 57. Sumitomo Pharma Description and Business Overview
  • Table 58. Sumitomo Pharma Antibiotic Drug Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Antibiotic Drug Business of Sumitomo Pharma (2020-2025)
  • Table 60. Sumitomo Pharma Recent Developments
  • Table 61. Fresenius Basic Information List
  • Table 62. Fresenius Description and Business Overview
  • Table 63. Fresenius Antibiotic Drug Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Antibiotic Drug Business of Fresenius (2020-2025)
  • Table 65. Fresenius Recent Developments
  • Table 66. AbbVie Basic Information List
  • Table 67. AbbVie Description and Business Overview
  • Table 68. AbbVie Antibiotic Drug Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Antibiotic Drug Business of AbbVie (2020-2025)
  • Table 70. AbbVie Recent Developments
  • Table 71. Hailin Pharmaceuticals Basic Information List
  • Table 72. Hailin Pharmaceuticals Description and Business Overview
  • Table 73. Hailin Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Antibiotic Drug Business of Hailin Pharmaceuticals (2020-2025)
  • Table 75. Hailin Pharmaceuticals Recent Developments
  • Table 76. Bausch Health Basic Information List
  • Table 77. Bausch Health Description and Business Overview
  • Table 78. Bausch Health Antibiotic Drug Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Antibiotic Drug Business of Bausch Health (2020-2025)
  • Table 80. Bausch Health Recent Developments
  • Table 81. Southwest Pharmaceuticals Basic Information List
  • Table 82. Southwest Pharmaceuticals Description and Business Overview
  • Table 83. Southwest Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Antibiotic Drug Business of Southwest Pharmaceuticals (2020-2025)
  • Table 85. Southwest Pharmaceuticals Recent Developments
  • Table 86. Zhuhai United Pharmaceuticals Basic Information List
  • Table 87. Zhuhai United Pharmaceuticals Description and Business Overview
  • Table 88. Zhuhai United Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Antibiotic Drug Business of Zhuhai United Pharmaceuticals (2020-2025)
  • Table 90. Zhuhai United Pharmaceuticals Recent Developments
  • Table 91. Qilu Pharmaceuticals Basic Information List
  • Table 92. Qilu Pharmaceuticals Description and Business Overview
  • Table 93. Qilu Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Antibiotic Drug Business of Qilu Pharmaceuticals (2020-2025)
  • Table 95. Qilu Pharmaceuticals Recent Developments
  • Table 96. China Resources Sanjiu Pharmaceuticals Basic Information List
  • Table 97. China Resources Sanjiu Pharmaceuticals Description and Business Overview
  • Table 98. China Resources Sanjiu Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Antibiotic Drug Business of China Resources Sanjiu Pharmaceuticals (2020-2025)
  • Table 100. China Resources Sanjiu Pharmaceuticals Recent Developments
  • Table 101. Shenzhen Xinlitai Pharmaceuticals Basic Information List
  • Table 102. Shenzhen Xinlitai Pharmaceuticals Description and Business Overview
  • Table 103. Shenzhen Xinlitai Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Antibiotic Drug Business of Shenzhen Xinlitai Pharmaceuticals (2020-2025)
  • Table 105. Shenzhen Xinlitai Pharmaceuticals Recent Developments
  • Table 106. Shanghai Modern Pharmaceuticals Basic Information List
  • Table 107. Shanghai Modern Pharmaceuticals Description and Business Overview
  • Table 108. Shanghai Modern Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Antibiotic Drug Business of Shanghai Modern Pharmaceuticals (2020-2025)
  • Table 110. Shanghai Modern Pharmaceuticals Recent Developments
  • Table 111. North China Pharmaceuticals Basic Information List
  • Table 112. North China Pharmaceuticals Description and Business Overview
  • Table 113. North China Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Antibiotic Drug Business of North China Pharmaceuticals (2020-2025)
  • Table 115. North China Pharmaceuticals Recent Developments
  • Table 116. Sun Pharmaceuticals Basic Information List
  • Table 117. Sun Pharmaceuticals Description and Business Overview
  • Table 118. Sun Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 119. Revenue (US$ Million) in Antibiotic Drug Business of Sun Pharmaceuticals (2020-2025)
  • Table 120. Sun Pharmaceuticals Recent Developments
  • Table 121. Hikma Pharmaceuticals Basic Information List
  • Table 122. Hikma Pharmaceuticals Description and Business Overview
  • Table 123. Hikma Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 124. Revenue (US$ Million) in Antibiotic Drug Business of Hikma Pharmaceuticals (2020-2025)
  • Table 125. Hikma Pharmaceuticals Recent Developments
  • Table 126. Shijiazhuang Pharmaceutical Group Basic Information List
  • Table 127. Shijiazhuang Pharmaceutical Group Description and Business Overview
  • Table 128. Shijiazhuang Pharmaceutical Group Antibiotic Drug Products, Services and Solutions
  • Table 129. Revenue (US$ Million) in Antibiotic Drug Business of Shijiazhuang Pharmaceutical Group (2020-2025)
  • Table 130. Shijiazhuang Pharmaceutical Group Recent Developments
  • Table 131. Resun Pharmaceuticals Basic Information List
  • Table 132. Resun Pharmaceuticals Description and Business Overview
  • Table 133. Resun Pharmaceuticals Antibiotic Drug Products, Services and Solutions
  • Table 134. Revenue (US$ Million) in Antibiotic Drug Business of Resun Pharmaceuticals (2020-2025)
  • Table 135. Resun Pharmaceuticals Recent Developments
  • Table 136. Key Raw Materials Lists
  • Table 137. Raw Materials Key Suppliers Lists
  • Table 138. Antibiotic Drug Downstream Customers
  • Table 139. Antibiotic Drug Distributors List
  • Table 140. Research Programs/Design for This Report
  • Table 141. Key Data Information from Secondary Sources
  • Table 142. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Antibiotic Drug Product Picture
  • Figure 2. Global Antibiotic Drug Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Antibiotic Drug Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Antibiotic Drug Report Years Considered
  • Figure 5. Global Antibiotic Drug Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Antibiotic Drug Revenue in 2024
  • Figure 7. Antibiotic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Oral Picture
  • Figure 9. Injection Picture
  • Figure 10. Other Picture
  • Figure 11. Global Antibiotic Drug Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Antibiotic Drug Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. B-lactams Picture
  • Figure 14. Tetracyclines Picture
  • Figure 15. Macrolides Picture
  • Figure 16. Aminoglycosides Picture
  • Figure 17. Peptides Picture
  • Figure 18. Quinolones Picture
  • Figure 19. Other Picture
  • Figure 20. Global Antibiotic Drug Sales Value by Drug (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 21. Global Antibiotic Drug Sales Value Market Share by Drug, 2024 & 2031
  • Figure 22. Product Picture of Hospitals
  • Figure 23. Product Picture of Retail Pharmacy
  • Figure 24. Product Picture of Other
  • Figure 25. Global Antibiotic Drug Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 26. Global Antibiotic Drug Sales Value Market Share by Application, 2024 & 2031
  • Figure 27. North America Antibiotic Drug Sales Value (2020-2031) & (US$ Million)
  • Figure 28. North America Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Europe Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Europe Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Asia Pacific Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Asia Pacific Antibiotic Drug Sales Value by Region (%), 2024 VS 2031
  • Figure 33. South America Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. South America Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Middle East & Africa Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. Middle East & Africa Antibiotic Drug Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Key Countries/Regions Antibiotic Drug Sales Value (%), (2020-2031)
  • Figure 38. United States Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Antibiotic Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Antibiotic Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Antibiotic Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Antibiotic Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Antibiotic Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Antibiotic Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Antibiotic Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Antibiotic Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Antibiotic Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Antibiotic Drug Industrial Chain
  • Figure 60. Antibiotic Drug Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed